Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Behnes

Showing results (121-130 of 330) with videos related to

Pageof 33
Sort By:
Journal of Clinical Medicine|May 27, 2023
Safety and Efficiency of Rotational Atherectomy in Chronic Total Coronary Occlusion-One-Year Clinical Outcomes of an Observational RegistryMohamed Ayoub, Noé Corpataux, Michael Behnes, et al.
Journal of the American College of Cardiology|February 25, 2017
Successful Percutaneous Coronary Intervention Improves Cardiopulmonary Exercise Capacity in Patients With Chronic Total OcclusionsKambis Mashayekhi, Hans Neuser, Anna Kraus, et al.
BMC Cardiovascular Disorders|June 15, 2015
Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin IUrsula Hoffmann, Florian Espeter, Christel Weiß, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2022
Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective StudyMohammad Abumayyaleh, Jonathan Demmer, Carina Krack, et al.
Coronary Artery Disease|May 4, 2023
The prothrombin time/international normalized ratio predicts prognosis in cardiogenic shockTobias Schupp, Michael Behnes, Jonas Rusnak, et al.
Frontiers in Cardiovascular Medicine|January 3, 2025
Sex differences and clinical outcomes, including ventricular tachyarrhythmias, of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanMohammad Abumayyaleh, Carina Krack, Jonathan Demmer, et al.
Scandinavian Cardiovascular Journal : SCJ|July 6, 2022
Digitalis therapy in patients with ventricular tachyarrhythmiasTobias Schupp, Julian Müller, Max von Zworowsky, et al.
Oncology Research and Treatment|February 7, 2018
Oxaliplatin-Induced Acute ST Segment Elevation Mimicking Myocardial Infarction: A Case ReportKathrin Weidner, Michael Behnes, Jenny Haas, et al.
Clinical Laboratory|August 10, 2023
Effect of Hemoglobin Levels in Patients with Cardiogenic Shock of Any Cause: Insights from a Single-Centre, Prospective RegistryJonas Dudda, Kathrin Weidner, Michael Behnes, et al.
Progress in Cardiovascular Diseases|March 24, 2026
Revascularization of patients with chronic total occlusion and left ventricular systolic dysfunctionGiuseppe Vadalà, Kambis Mashayekhi, Cristina Madaudo, et al.
Pageof 33

Showing results (121-130 of 330) with videos related to

Sort By:
Pageof 33
Journal of Clinical Medicine|May 27, 2023
Safety and Efficiency of Rotational Atherectomy in Chronic Total Coronary Occlusion-One-Year Clinical Outcomes of an Observational RegistryMohamed Ayoub, Noé Corpataux, Michael Behnes, et al.
Journal of the American College of Cardiology|February 25, 2017
Successful Percutaneous Coronary Intervention Improves Cardiopulmonary Exercise Capacity in Patients With Chronic Total OcclusionsKambis Mashayekhi, Hans Neuser, Anna Kraus, et al.
BMC Cardiovascular Disorders|June 15, 2015
Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin IUrsula Hoffmann, Florian Espeter, Christel Weiß, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|March 30, 2022
Hemodynamic Effects of Sacubitril/Valsartan in Patients with Reduced Left Ventricular Ejection Fraction Over 24 Months: A Retrospective StudyMohammad Abumayyaleh, Jonathan Demmer, Carina Krack, et al.
Coronary Artery Disease|May 4, 2023
The prothrombin time/international normalized ratio predicts prognosis in cardiogenic shockTobias Schupp, Michael Behnes, Jonas Rusnak, et al.
Frontiers in Cardiovascular Medicine|January 3, 2025
Sex differences and clinical outcomes, including ventricular tachyarrhythmias, of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartanMohammad Abumayyaleh, Carina Krack, Jonathan Demmer, et al.
Scandinavian Cardiovascular Journal : SCJ|July 6, 2022
Digitalis therapy in patients with ventricular tachyarrhythmiasTobias Schupp, Julian Müller, Max von Zworowsky, et al.
Oncology Research and Treatment|February 7, 2018
Oxaliplatin-Induced Acute ST Segment Elevation Mimicking Myocardial Infarction: A Case ReportKathrin Weidner, Michael Behnes, Jenny Haas, et al.
Clinical Laboratory|August 10, 2023
Effect of Hemoglobin Levels in Patients with Cardiogenic Shock of Any Cause: Insights from a Single-Centre, Prospective RegistryJonas Dudda, Kathrin Weidner, Michael Behnes, et al.
Progress in Cardiovascular Diseases|March 24, 2026
Revascularization of patients with chronic total occlusion and left ventricular systolic dysfunctionGiuseppe Vadalà, Kambis Mashayekhi, Cristina Madaudo, et al.
Pageof 33